Skip to content
	
	
	
		
							
			
				
					
					
						
						
	
				
		
	
		 
	
	
					
				Author(s): WHO
Filed under: 
DR-TB, 
drug safety, 
drug safety monitoring, 
Drug-resistant TB, 
Guidelines, 
Management, 
management framework, 
performance indicators, 
TB, 
Treatment, 
treatment regimens, 
Tuberculosis, 
WHO, 
World Health Organization